Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 218 publications
Circumventing Ewing sarcoma tumor microenvironment resistance by IL1RAP CAR-modified TGFβ1-imprinted natural killer cells in combination with IL-15 agonist and anti-GD2 antibody.
Journal: Journal for immunotherapy of cancer
Published: June 24, 2026
Hemophagocytic lymphohistiocytosis: new grading classification and targeted therapies.
Journal: Clinical advances in hematology & oncology : H&O
Published: May 07, 2026
Erratum: Efficiently targeting neuroblastoma with the combination of anti-ROR1 CAR NK cells and N-803 in vitro and in vivo in NB xenografts.
Journal: Molecular therapy. Oncology
Published: February 09, 2026
A framework integrating multiscale in silico modeling and experimental data predicts CAR-NK cell cytotoxicity across target cell types.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 30, 2026
Immune checkpoint therapy in pediatric and adolescent lymphomas.
Journal: Haematologica
Published: January 19, 2026
Advances in augmenting infiltration of active natural killer cells into pediatric and adult solid tumors.
Journal: Molecular therapy. Oncology
Published: October 20, 2025
Targeted immunotherapy in the treatment of childhood and adolescent mature B-cell lymphoma.
Journal: Clinical advances in hematology & oncology : H&O
Published: October 06, 2025
CXCL10-induced chemotaxis of ex vivo-expanded natural killer cells combined with NKTR-255 enhances anti-tumor efficacy in osteosarcoma.
Journal: Molecular therapy. Oncology
Published: July 25, 2025
CD19 CAR T-Cell Therapy for Primary Mediastinal Large B-Cell Lymphoma: A CIBMTR Analysis.
Journal: American journal of hematology
Published: July 09, 2025
Persistent Epstein-Barr virus viremia in NK-/T-cell lymphoma: bad boys for life!
Journal: Haematologica
Published: May 08, 2025
Last Updated: 09/26/2026